Literature DB >> 20859709

Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.

Yi-Wen Zhang1, Hong-Qiang Xie, Yu Chen, Bo Jiao, Zhi-Xiang Shen, Sai-Juan Chen, Wei-Li Zhao.   

Abstract

The positive regulatory domain I (PRDM1) is a transcriptional repressor that plays an important role in the B-cell differentiation. PRDM1β isoform is functionally impaired and overexpressed in a subset of diffuse large B-cell lymphoma with aggressive behavior. To investigate the possible epigenetic alteration on PRDM1β expression, methylation of PRDM1β promoter was assessed in B-lymphoma cell lines by bisulfite-sequencing PCR and screened in tumor samples of DLBCL patients using MassARRAY-quantitative methylation analysis. PRDM1β expression corresponded to promoter methylation status. CpG island of PRDM1β promoter possessed significant transcriptional activity, which could be modified by methylation. Loss of promoter methylation of PRDM1β was more frequently detected in lymphoma samples than in reactive hyperplasia. Thus, demethylation of abnormal tumor suppressor gene isoform might be linked to lymphoma progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859709     DOI: 10.1007/s12185-010-0689-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  7 in total

Review 1.  Leukaemogenesis: more than mutant genes.

Authors:  Jianjun Chen; Olatoyosi Odenike; Janet D Rowley
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

2.  Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.

Authors:  Y Du; T Carling; W Fang; Z Piao; J C Sheu; S Huang
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

3.  Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.

Authors:  Ildikó Györy; György Fejér; Nilanjan Ghosh; Ed Seto; Kenneth L Wright
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Authors:  Yan-Yan Liu; Christophe Leboeuf; Jing-Yi Shi; Jun-Min Li; Li Wang; Yang Shen; José-Francisco Garcia; Zhi-Xiang Shen; Zhu Chen; Anne Janin; Sai-Juan Chen; Wei-Li Zhao
Journal:  Blood       Date:  2007-03-22       Impact factor: 22.113

5.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

Authors:  Mathias Ehrich; Matthew R Nelson; Patrick Stanssens; Marc Zabeau; Triantafillos Liloglou; George Xinarianos; Charles R Cantor; John K Field; Dirk van den Boom
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.

Authors:  Yoshiyuki Watanabe; Minoru Toyota; Yutaka Kondo; Hiromu Suzuki; Takashi Imai; Mutsumi Ohe-Toyota; Reo Maruyama; Masanori Nojima; Yasushi Sasaki; Yoshitaka Sekido; Hiroyoshi Hiratsuka; Yasuhisa Shinomura; Kohzoh Imai; Fumio Itoh; Takashi Tokino
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

  7 in total
  2 in total

1.  Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.

Authors:  Katerina Vrzalikova; Sarah Leonard; Yichao Fan; Andrew Bell; Martina Vockerodt; Patrik Flodr; Kenneth L Wright; Martin Rowe; Qian Tao; Paul G Murray
Journal:  Pathogens       Date:  2012-10-08

2.  Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Authors:  Raquel Romero-García; Laura Gómez-Jaramillo; Rosa María Mateos; Gema Jiménez-Gómez; Nuria Pedreño-Horrillo; Esther Foncubierta; Juan Francisco Rodríguez-Gutiérrez; Sebastián Garzón; Francisco Mora-López; Carmen Rodríguez; Luis M Valor; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.